Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CARD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TEN1-CDK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CCDC152 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDS5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC25A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPRIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCNN1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on